Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
30
07
2018
accepted:
21
11
2018
pubmed:
13
1
2019
medline:
21
5
2020
entrez:
13
1
2019
Statut:
ppublish
Résumé
Prognosis for women with epithelial ovarian cancer remains poor. One new molecular target in epithelial ovarian cancer is folate receptor alpha (FRα). This commentary discusses the characteristics that contribute to its attractiveness as a candidate for therapeutic intervention.
Identifiants
pubmed: 30635448
pii: theoncologist.2018-0459
doi: 10.1634/theoncologist.2018-0459
pmc: PMC6459241
doi:
Substances chimiques
Antineoplastic Agents
0
Folate Receptor 1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
425-429Déclaration de conflit d'intérêts
Disclosures of potential conflicts of interest may be found at the end of this article.
Références
Cancer Res. 2006 Mar 15;66(6):3214-21
pubmed: 16540673
J Nucl Med. 2014 May;55(5):701-4
pubmed: 24732155
J Clin Oncol. 2017 Apr 1;35(10):1112-1118
pubmed: 28029313
J Clin Oncol. 2013 Dec 10;31(35):4400-6
pubmed: 24127448
J Nucl Med. 2008 Jun;49(6):899-906
pubmed: 18483093
Springerplus. 2012 Sep 28;1:22
pubmed: 23961352
Future Oncol. 2018 Jan;14(2):123-136
pubmed: 29098867
J Clin Oncol. 2016 Jul 1;34(19):2271-8
pubmed: 27001568
Expert Opin Drug Deliv. 2008 Mar;5(3):309-19
pubmed: 18318652
Mol Cancer Ther. 2015 Jul;14(7):1605-13
pubmed: 25904506
Gynecol Oncol. 2007 Jun;105(3):563-70
pubmed: 17400285
Int J Clin Exp Pathol. 2015 May 01;8(5):5633-41
pubmed: 26191275
Mol Cancer Ther. 2016 Aug;15(8):1998-2008
pubmed: 27256377
Gynecol Oncol. 2013 Jul;130(1):192-9
pubmed: 23558051
Adv Drug Deliv Rev. 2004 Apr 29;56(8):1067-84
pubmed: 15094207
Arch Pathol Lab Med. 2014 Jul;138(7):890-5
pubmed: 24028341
Anticancer Res. 2008 Nov-Dec;28(6A):3567-72
pubmed: 19189636
Cancer Metastasis Rev. 2015 Mar;34(1):41-52
pubmed: 25564455
Onco Targets Ther. 2014 Jul 10;7:1223-36
pubmed: 25031539
Onco Targets Ther. 2016 Mar 07;9:1181-8
pubmed: 27022278
Arch Pathol Lab Med. 2013 Feb;137(2):241-4
pubmed: 22984810
Gynecol Oncol. 2017 Nov;147(2):402-407
pubmed: 28843653
Gynecol Oncol. 2013 Jun;129(3):452-8
pubmed: 23474348
Int J Womens Health. 2014 Mar 31;6:351-8
pubmed: 24729732
J Thorac Oncol. 2012 May;7(5):833-40
pubmed: 22729036
Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):567-572
pubmed: 27941566
Anal Biochem. 2005 Mar 15;338(2):284-93
pubmed: 15745749